Total Payments
$4,210
2024 Payments
$545.66
Companies
32
Transactions
320
Medicare Patients
5,056
Medicare Billing
$402,290
Payment Breakdown by Category
Food & Beverage$4,033 (95.8%)
Gifts$106.00 (2.5%)
Education$71.02 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,033 | 317 | 95.8% |
| Gift | $106.00 | 1 | 2.5% |
| Education | $71.02 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $745.46 | 61 | $0 (2022) |
| ABBVIE INC. | $646.74 | 45 | $0 (2024) |
| PFIZER INC. | $371.01 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $244.33 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $233.45 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $197.67 | 30 | $0 (2022) |
| Amgen Inc. | $191.70 | 14 | $0 (2024) |
| Allergan Inc. | $176.49 | 20 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $144.06 | 8 | $0 (2024) |
| Novo Nordisk Inc | $143.78 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $545.66 | 34 | Novartis Pharmaceuticals Corporation ($141.11) |
| 2023 | $852.21 | 53 | AbbVie Inc. ($280.30) |
| 2022 | $492.91 | 33 | ABBVIE INC. ($131.57) |
| 2021 | $281.67 | 21 | AbbVie Inc. ($132.72) |
| 2020 | $173.63 | 13 | Sunovion Pharmaceuticals Inc. ($120.33) |
| 2019 | $520.95 | 43 | Sunovion Pharmaceuticals Inc. ($203.48) |
| 2018 | $739.13 | 55 | Sunovion Pharmaceuticals Inc. ($247.76) |
| 2017 | $603.72 | 68 | Allergan Inc. ($129.98) |
All Payment Transactions
320 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Bone Health | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Gastroenterology | ||||||
| 08/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: PAIN | ||||||
| 07/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: DIABETES | ||||||
| 07/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| Category: Cardiovascular | ||||||
| 06/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: UROLOGY | ||||||
| 06/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,418 | 1,613 | $852,685 | $113,647 |
| 2022 | 9 | 1,125 | 1,235 | $760,808 | $86,836 |
| 2021 | 9 | 983 | 1,084 | $636,833 | $76,103 |
| 2020 | 14 | 1,530 | 1,855 | $994,543 | $125,704 |
Total Patients
5,056
Total Services
5,787
Medicare Billing
$402,290
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 108 | 110 | $75,320 | $10,152 | 13.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 43 | 43 | $74,346 | $7,936 | 10.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 36 | $12,384 | $5,540 | 44.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 54 | 55 | $15,566 | $2,865 | 18.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 48 | $5,856 | $2,652 | 45.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 361 | 420 | $24,379 | $2,596 | 10.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 20 | 22 | $2,706 | $1,218 | 45.0% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2021 | 38 | 38 | $5,358 | $560.50 | 10.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 465 | 513 | $689,664 | $68,897 | 10.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 126 | 139 | $86,730 | $12,123 | 14.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 88 | 209 | $25,498 | $11,722 | 46.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 59 | 60 | $103,643 | $10,846 | 10.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 91 | 114 | $14,022 | $6,426 | 45.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 536 | 645 | $33,801 | $4,262 | 12.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 24 | $8,256 | $3,782 | 45.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 59 | 62 | $19,282 | $2,744 | 14.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 24 | $4,224 | $1,952 | 46.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 16 | $3,744 | $1,713 | 45.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 11 | 11 | $1,353 | $620.24 | 45.8% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2020 | 14 | 14 | $1,974 | $265.82 | 13.5% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 12 | 12 | $1,176 | $211.11 | 18.0% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 12 | 12 | $1,176 | $141.12 | 12.0% |
About Dr. Jerzy Slomka, MD
Dr. Jerzy Slomka, MD is a Family Medicine healthcare provider based in Ellsworth, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467452904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerzy Slomka, MD has received a total of $4,210 in payments from pharmaceutical and medical device companies, with $545.66 received in 2024. These payments were reported across 320 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,033).
As a Medicare-enrolled provider, Slomka has provided services to 5,056 Medicare beneficiaries, totaling 5,787 services with total Medicare billing of $402,290. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Internal Medicine
- Location Ellsworth, KS
- Active Since 07/27/2005
- Last Updated 12/17/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1467452904
Products in Payments
- VRAYLAR (Drug) $309.62
- LONHALA MAGNAIR (Drug) $247.23
- UBRELVY (Drug) $207.92
- GEMTESA (Drug) $207.90
- FARXIGA (Drug) $161.56
- Utibron (Drug) $145.24
- XARELTO (Drug) $125.22
- ENTRESTO (Drug) $124.03
- CHANTIX (Drug) $123.71
- XIFAXAN (Drug) $117.02
- LEQVIO (Drug) $109.42
- WASTE BOTTLE W/CAP & SENSOR, 360 (Medical Supply) $106.00
- ELIQUIS (Drug) $98.55
- TOUJEO (Drug) $86.59
- TRULICITY (Drug) $86.09
- LYRICA (Drug) $86.07
- UTIBRON NEOHALER (Drug) $83.37
- LINZESS (Drug) $80.99
- NURTEC ODT (Drug) $80.44
- UTIBRON (Drug) $78.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ellsworth
Ronald Whitmer, Do, DO
Family Medicine — Payments: $4,137
Family Medicine $4,137
Eastin Casey
Family Medicine — Payments: $1,892
Family Medicine $1,892
Starie Seay, Md, MD
Family Medicine — Payments: $308.41
Family Medicine $308.41
Ethan Percy, Do, DO
Family Medicine — Payments: $91.27
Family Medicine $91.27
Mr. Martin Higgins, M.d, M.D
Family Medicine — Payments: $71.76
Family Medicine $71.76
Daniel Reinke, Md, MD
Family Medicine — Payments: $24.18
Family Medicine $24.18